Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heritability of strabismus: genetic influence is specific to eso-deviation and independent of refractive error.
Sanfilippo PG, Hammond CJ, Staffieri SE, Kearns LS, Melissa Liew SH, Barbour JM, Hewitt AW, Ge D, Snieder H, Mackinnon JR, Brown SA, Lorenz B, Spector TD, Martin NG, Wilmer JB, Mackey DA. Sanfilippo PG, et al. Among authors: brown sa. Twin Res Hum Genet. 2012 Oct;15(5):624-30. doi: 10.1017/thg.2012.22. Epub 2012 Jun 13. Twin Res Hum Genet. 2012. PMID: 22877876
Effect of whiplash injury on accommodation.
Brown S. Brown S. Clin Exp Ophthalmol. 2003 Oct;31(5):424-9. doi: 10.1046/j.1442-9071.2003.00690.x. Clin Exp Ophthalmol. 2003. PMID: 14516431
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes.
Levy CJ, Bailey R, Laffel LM, Forlenza G, DiMeglio LA, Hughes MS, Brown SA, Aleppo G, Bhargava A, Shah VN, Clements MA, Kipnes M, Bruggeman B, Daniels M, Rodriguez H, Calhoun P, Lum JW, Sasson-Katchalski R, Pinsker JE, Pollom R, Beck RW; TL1 Study Group. Levy CJ, et al. Among authors: brown sa. Diabetes Technol Ther. 2024 May 22. doi: 10.1089/dia.2024.0048. Online ahead of print. Diabetes Technol Ther. 2024. PMID: 38696672
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation.
Yaeger R, McKean MA, Haq R, Beck JT, Taylor MH, Cohen JE, Bowles DW, Gadgeel SM, Mihalcioiu C, Papadopoulos KP, Diamond EL, Sturtz KB, Feng G, Drescher SK, Reddy MB, Sengupta B, Maity AK, Brown SA, Singh A, Brown EN, Baer BR, Wong J, Mou TC, Wu WI, Kahn DR, Gadal S, Rosen N, Gaudino JJ, Lee PA, Hartley DP, Rothenberg SM. Yaeger R, et al. Among authors: brown sa. Cancer Discov. 2024 Apr 30. doi: 10.1158/2159-8290.CD-24-0024. Online ahead of print. Cancer Discov. 2024. PMID: 38691346
1,410 results